06/04/2018
Containment, Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV), Outbreak response, Vaccines
Coffee with Polio Experts: Dr Ondrej Mach, WHO
Why we are developing new polio vaccines for the post-eradication era.
Ondrej Mach of the WHO polio research team discusses why new inactivated polio vaccine solutions are needed for the post-eradication era. Why are we developing entirely new vaccines for a disease which will no longer exist?
Related News
19/10/2021
For a few incredible eradicators, a life’s purpose doesn’t stop at retirement
10/10/2021
The recommendation further advances nOPV2 as a critical new tool in the fight against circulating vaccine-derived poliovirus type 2 (cVDPV2)
29/09/2021
More often than not, the road to a meaningful triumph is a bumpy one.
27/08/2021
Learn how the type 2 novel oral polio vaccine (nOPV2) is being rolled out across Africa to help more sustainably address outbreaks of a non-wild form of polio, cVDPV2, and protect children across the continent.
24/06/2021
Pakistan is one of two countries where wild poliovirus remains endemic making it essential that the entire country supports the successful implementation of every polio campaign. Women play a critical role, often working at polio’s frontline.
23/06/2021
Update on polio eradication efforts in Pakistan for April 2021
